• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催乳素和src/abl激酶对STAT5B和STAT5A核转位的不同作用。

Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.

作者信息

Kazansky A V, Kabotyanski E B, Wyszomierski S L, Mancini M A, Rosen J M

机构信息

Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030-3498, USA.

出版信息

J Biol Chem. 1999 Aug 6;274(32):22484-92. doi: 10.1074/jbc.274.32.22484.

DOI:10.1074/jbc.274.32.22484
PMID:10428824
Abstract

In this study, DNA binding and tyrosine phosphorylation of STAT5A and STAT5B were compared with their subcellular localization determined using indirect immunofluorescence microscopy. Following prolactin activation, both STAT5A and STAT5B were rapidly translocated into the nucleus and displayed a detergent-resistant, punctate nuclear staining pattern. Similar to prolactin induction, src activation resulted in tyrosine phosphorylation and DNA binding of both STAT5A and STAT5B. However, nuclear translocation of only STAT5B but not STAT5A was observed. This selective nuclear translocation appears to be mediated via the carboxyl-terminal sequences in STAT5B. Furthermore, overexpression of a dominant negative kinase-inactive mutant of JAK2 prevented prolactin-induced tyrosine phosphorylation and nuclear translocation of STAT5A and STAT5B but did not block src kinase activation and nuclear translocation of STAT5B. In co-transfection assays, prolactin-mediated activation but not src kinase-mediated activation of STAT5B resulted in the induction of a beta-casein promoter-driven reporter construct. These results suggest that STAT5 activation by src may occur by a mechanism distinct from that employed in cytokine activation of the JAK/STAT pathway, resulting in the selective nuclear translocation of STAT5B.

摘要

在本研究中,将STAT5A和STAT5B的DNA结合及酪氨酸磷酸化与其通过间接免疫荧光显微镜确定的亚细胞定位进行了比较。催乳素激活后,STAT5A和STAT5B均迅速转位至细胞核,并呈现出耐去污剂的点状核染色模式。与催乳素诱导相似,src激活导致STAT5A和STAT5B的酪氨酸磷酸化及DNA结合。然而,仅观察到STAT5B而非STAT5A的核转位。这种选择性核转位似乎是通过STAT5B中的羧基末端序列介导的。此外,JAK2的显性负性激酶失活突变体的过表达可阻止催乳素诱导的STAT5A和STAT5B的酪氨酸磷酸化及核转位,但不阻断src激酶激活及STAT5B的核转位。在共转染实验中,催乳素介导的STAT5B激活而非src激酶介导的激活导致了β-酪蛋白启动子驱动的报告基因构建体的诱导。这些结果表明,src对STAT5的激活可能通过一种不同于JAK/STAT途径细胞因子激活所采用的机制发生,导致STAT5B的选择性核转位。

相似文献

1
Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.催乳素和src/abl激酶对STAT5B和STAT5A核转位的不同作用。
J Biol Chem. 1999 Aug 6;274(32):22484-92. doi: 10.1074/jbc.274.32.22484.
2
An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.一种免疫组织化学方法,用于监测催乳素诱导的胰岛中JAK2/STAT5信号通路的激活。
J Histochem Cytochem. 2002 Mar;50(3):365-83. doi: 10.1177/002215540205000308.
3
A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.一种胞质蛋白酪氨酸磷酸酶PTP1B可特异性地使催乳素激活的STAT5a和STAT5b去磷酸化并使其失活。
J Biol Chem. 2000 Dec 15;275(50):39718-26. doi: 10.1074/jbc.M005615200.
4
PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.催乳素诱导的雌激素受体α基因表达由Janus激酶2(Jak2)介导,而信号转导及转录激活因子5b(Stat5b)的磷酸化涉及Jak2和另一种酪氨酸激酶。
Mol Endocrinol. 2001 Nov;15(11):1941-52. doi: 10.1210/mend.15.11.0722.
5
Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.SHP-2 酪氨酸磷酸酶的显性负性变体可抑制 Jak2(Janus 激酶 2)的催乳素激活以及 Stat5(信号转导子和转录激活子 5)依赖性转录的诱导。
Mol Endocrinol. 1998 Apr;12(4):556-67. doi: 10.1210/mend.12.4.0086.
6
Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.催乳素受体通过两条独立的途径调节Stat5酪氨酸磷酸化和核转位。
J Biol Chem. 1998 Mar 27;273(13):7709-16. doi: 10.1074/jbc.273.13.7709.
7
Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells.催乳素敏感细胞中Stat5a的脯氨酸毗邻丝氨酸残基Ser725和Stat5b的Ser730磷酸化状态的差异调控。
J Biol Chem. 1998 Nov 13;273(46):30218-24. doi: 10.1074/jbc.273.46.30218.
8
Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.MGF-Stat5羧基末端反式激活结构域的缺失导致持续的DNA结合及显性负性表型。
Mol Cell Biol. 1996 Oct;16(10):5691-700. doi: 10.1128/MCB.16.10.5691.
9
Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b.由催乳素和Src调节的信号转导通路会导致活化的Stat5b产生不同的构象。
J Biol Chem. 2003 May 9;278(19):17218-27. doi: 10.1074/jbc.M301578200. Epub 2003 Mar 5.
10
Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.Stat5介导的转录抑制。生长相关启动子与分化特异性启动子的差异活性。
J Biol Chem. 1997 Oct 24;272(43):26841-9. doi: 10.1074/jbc.272.43.26841.

引用本文的文献

1
Differential regulatory effects of the N-terminal region in SYK-fusion kinases reveal unique activation-inducible nuclear translocation of ITK-SYK.SYK融合激酶中N端区域的差异调节作用揭示了ITK-SYK独特的激活诱导核转位。
Sci Rep. 2025 Jan 4;15(1):814. doi: 10.1038/s41598-024-83962-8.
2
STAT signaling in polycystic kidney disease.STAT 信号通路在多囊肾病中的作用。
Cell Signal. 2020 Aug;72:109639. doi: 10.1016/j.cellsig.2020.109639. Epub 2020 Apr 20.
3
Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?信号转导和转录激活因子的核质穿梭:一个干预靶点?
Cancers (Basel). 2019 Nov 19;11(11):1815. doi: 10.3390/cancers11111815.
4
Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.癌症与炎症中的信号转导和转录激活因子(STATs)蛋白:功能及治疗意义
Front Oncol. 2019 Feb 21;9:48. doi: 10.3389/fonc.2019.00048. eCollection 2019.
5
Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.驱动前列腺癌进展的雄激素受体依赖性和非依赖性机制:多视角治疗靶点的机遇
Oncotarget. 2017 Jan 10;8(2):3724-3745. doi: 10.18632/oncotarget.12554.
6
Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets.剖析前列腺癌发生发展中的主要信号通路:机制与新型治疗靶点。
J Steroid Biochem Mol Biol. 2017 Feb;166:16-27. doi: 10.1016/j.jsbmb.2016.07.006. Epub 2016 Jul 30.
7
3,3'-Diindolylmethane Inhibits Flt3L/GM-CSF-induced-bone Marrow-derived CD103(+) Dendritic Cell Differentiation Regulating Phosphorylation of STAT3 and STAT5.3,3'-二吲哚甲烷抑制Flt3L/GM-CSF诱导的骨髓源性CD103(+)树突状细胞分化,调节STAT3和STAT5的磷酸化
Immune Netw. 2015 Dec;15(6):278-90. doi: 10.4110/in.2015.15.6.278. Epub 2015 Dec 24.
8
Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.Src家族激酶通过磷酸酪氨酸-SH2结构域相互作用干扰STAT5A的二聚化。
Cell Commun Signal. 2015 Feb 15;13:10. doi: 10.1186/s12964-014-0081-7.
9
Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.信号转导及转录激活因子5b通过抑制凋亡在血小板衍生生长因子B依赖的神经干细胞样胶质瘤模型中驱动恶性进展。
Int J Cancer. 2015 May 1;136(9):2047-54. doi: 10.1002/ijc.29264. Epub 2014 Oct 23.
10
BCR-ABL affects STAT5A and STAT5B differentially.BCR-ABL 对 STAT5A 和 STAT5B 的影响不同。
PLoS One. 2014 May 16;9(5):e97243. doi: 10.1371/journal.pone.0097243. eCollection 2014.